Underuse of surgical resection among elderly patients with early-stage pancreatic cancer

Surgery (United States)

Volumn 158, Issue 5, 2015, Pages 1226-1234

  He, Weiguo ^a   Zhao, Hui ^a   Chan, Wenyaw ^b   Lopez, David ^b   Shroff, Rachna T ^a   Giordano, Sharon H ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR VOLUME; ADENOCARCINOMA; AGE; CANCER REGISTRY; MORTALITY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PATIENT SELECTION; SURVIVAL RATE; UNITED STATES; VERY ELDERLY;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TEXAS;

EID: 84944153570     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.04.031     Document Type: Article

References (24)

1. M.F. Brennan Adjuvant therapy following resection for pancreatic adenocarcinoma Surg Oncol Clin N Am 13 2004 555 566
2. A. Stojadinovic, A. Hoos, M.F. Brennan, and K.C. Conlon Randomized clinical trials in pancreatic cancer Surg Oncol Clin N Am 11 2002 207 229
3. N. Howlader, A.M. Noone, M. Krapcho, and et al. SEER Cancer Statistics Review, 1975-2010 2013 National Cancer Institute Bethesda, MD [cited 2014 Mar 4]. Available from: http://seer.cancer.gov/csr/1975-2010/
4. National Comprehensive Cancer Network (NCCN) NCCN Clinical practice guidelines in oncology. Pancreatic adenocarcinoma 2000 NCCN Fort Washington (APA)
5. S. Cascinu, M. Falconi, V. Valentini, and S. Jelic Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 2010 v55 v58
6. Surveillance, Epidemiology, and End Results Program. SEER report on pancreatic cancer [cited 2014 Mar 19]. Available from: http://seer.cancer.gov/statfacts/html/pancreas.html.
7. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
8. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
9. C.N. Klabunde, L.C. Harlan, and J.L. Warren Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients Med Care 44 2006 921 928
10. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, A.K. Stewart, D.P. Winchester, and M.S. Talamonti National failure to operate on early stage pancreatic cancer Ann Surg 246 2007 173 180
11. T.S. Riall, J.L. Cameron, K.D. Lillemoe, J.M. Winter, K.A. Campbell, R.H. Hruban, and et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- and 10-year follow-up Surgery 140 2006 764 772
12. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Cancer-directed surgery for localized disease: decreased use in the elderly Ann Surg Oncol 11 2004 962 969
13. N.N. Baxter, B.A. Whitson, and T.M. Tuttle Trends in the treatment of outcome of pancreatic cancer in the United States Ann Surg Oncol 14 2007 1320 1326
14. F.L. Lucas, T.A. Stukel, A.M. Morris, A.E. Siewers, and J.D. Birkmeyer Race and surgical mortality in the United States Ann Surg 243 2006 281 286
15. M.A. Eloubeidi, R.A. Desmond, C.M. Wilcox, R.J. Wilson, P. Manchikalapati, M.M. Fouad, and et al. Prognostic factors for survival in pancreatic cancer: a population-based study Am J Surg 192 2006 322 329
16. S.F. Sener, A. Fremgen, H.R. Menck, and D.P. Winchester Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1999 1 7
17. T.A. Sohn, C.J. Yeo, J.L. Cameron, K.D. Lillemoe, M.A. Talamini, R.H. Hruban, and et al. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg 2 1998 207 216
18. M.A. Makary, J.M. Winter, J.L. Cameron, K.A. Campbell, D. Chang, S.C. Cunningham, and et al. Pancreaticoduodenectomy in the very elderly J Gastrointest Surg 10 2006 347 356
19. M. Wagner, C. Redaelli, M. Lietz, C.A. Seiler, H. Friess, and M.W. Büchler Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 2004 586 594
20. J.P. Neoptolemos, D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, H. Hickey, and et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
21. T.S. Riall, W.H. Nealon, J.S. Goodwin, D. Zhang, Y.F. Kuo, C.M. Townsend Jr., and et al. Pancreatic cancer in the general population: improvements in survival over the last decade J Gastrointest Surg 10 2006 1212 1223
22. T.S. Riall, K.M. Sheffield, Y.F. Kuo, C.M. Townsend Jr., and J.S. Goodwin Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality J Am Geriatr Soc 59 2011 647 654
23. B.C. Visser, Y. Ma, Y. Zak, G.A. Poultsides, J.A. Norton, and K.F. Rhoads Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes HPB (Oxford) 14 2012 539 547
24. J.L. Cameron, T.S. Riall, J. Coleman, and K.A. Belcher One thousand consecutive pancreaticoduodenectomies Ann Surg 244 2006 10 15